Literature DB >> 30007039

Clinico-radiographic evaluation of 1% alendronate gel as an adjunct and smart blood derivative platelet rich fibrin in grade II furcation defects.

Ishita Wanikar1, Surekha Rathod1, Abhay P Kolte1.   

Abstract

BACKGROUND: The treatment of molar furcation involvement is unpredictable due to the complex anatomy and poor access for instrumentation. Previous studies have reported successful regeneration with endogenous regenerative material such as platelet rich fibrin (PRF) and bisphosphonates as alendronate (ALN). Hence, the present study was aimed to evaluate clinically and radiographically the efficacy of 1% ALN gel in combination with PRF (PRF+ALN) and PRF alone in the treatment of grade II furcation defects.
METHODS: A split mouth study with 40 bilateral furcation defects was randomly divided into PRF group and PRF+ALN group. Bone defect volume was the primary outcome evaluated at the end of 6 months with CBCT while the secondary outcomes being changes in clinical parameters including Probing pocket depth (PPD), Clinical attachment level (CAL) and Horizontal probing depth (HPD) recorded at baseline, 3 and 6 months.
RESULTS: The mean reduction in PPD, CAL and HPD was 1.85 ± 0.59 mm, 1.9 ± 0.64 mm and 1.7 ± 0.73 mm respectively for PRF group and 2.85 ± 0.88 mm, 3.05 ± 0.98 mm and 2.3 ± 0.73 mm respectively for PRF+ ALN group (p < 0.05). At the end of 6 months, mean reduction in bone defect volume for PRF and PRF+ ALN group was 8.65 ± 3.84 mm3 and 11.98 ± 4.13 mm3 respectively.
CONCLUSION: PRF+ ALN treated defects exhibited better clinical and radiographic outcomes suggestive of enhanced periodontal regeneration when compared to PRF alone treated sites.
© 2018 American Academy of Periodontology.

Entities:  

Keywords:  furcation lesions and treatment; growth factors; osteoclast(s); periodontal regeneration

Mesh:

Substances:

Year:  2018        PMID: 30007039     DOI: 10.1002/JPER.18-0146

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  6 in total

Review 1.  Bone replacement grafts with guided tissue regeneration in treatment of grade II furcation defects: a systematic review and meta-analysis.

Authors:  Renuka K Swami; Abhay P Kolte; Girish H Bodhare; Rajashri A Kolte
Journal:  Clin Oral Investig       Date:  2021-01-12       Impact factor: 3.573

2.  Evaluation of the clinical efficacy of 1.2% atorvastatin in the treatment of periodontal intraosseous defects by CBCT: A randomized controlled clinical trial.

Authors:  Prerna Y Shirke; Abhay P Kolte; Rajashri A Kolte; Pranjali V Bawanakar
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2019-10-07

3.  Adjuvant therapy with 1% alendronate gel for experimental periodontitis treatment in rats.

Authors:  Natália de Campos Kajimoto; Yvonne de Paiva Buischi; Peter Michael Loomer; Timothy G Bromage; Edilson Ervolino; Stephen Enrico Fucini; Natália Marcumini Pola; Beatriz Ommati Pirovani; Maria Juliana Sismeiro Morábito; Juliano Milanezi de Almeida; Flávia Aparecida Chaves Furlaneto; Maria José Hitomi Nagata
Journal:  J Periodontal Implant Sci       Date:  2021-12       Impact factor: 2.614

4.  Randomized, controlled clinical trial to evaluate efficacy of sticky bone and concentrated growth factor in the management of intrabony defects: 12 months follow-up study.

Authors:  Dhanashree Ghoderao; Surekha Rathod; Abhay Pandurang Kolte; Pranjali Bawankar; Ashwini Jadhav
Journal:  Dent Res J (Isfahan)       Date:  2022-08-16

Review 5.  Platelet-Rich Fibrin as a Bone Graft Material in Oral and Maxillofacial Bone Regeneration: Classification and Summary for Better Application.

Authors:  Yiping Liu; Xiaolin Sun; Jize Yu; Jia Wang; Peisong Zhai; Siyu Chen; Manxuan Liu; Yanmin Zhou
Journal:  Biomed Res Int       Date:  2019-12-06       Impact factor: 3.411

Review 6.  The Adjunctive Use of Leucocyte- and Platelet-Rich Fibrin in Periodontal Endosseous and Furcation Defects: A Systematic Review and Meta-Analysis.

Authors:  Eudoxie Pepelassi; Maria Deligianni
Journal:  Materials (Basel)       Date:  2022-03-11       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.